HUMACYTE INC's ticker is and the CUSIP is 44486Q111. A total of 16 filers reported holding HUMACYTE INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,844 | -1.7% | 62,500 | 0.0% | 0.00% | – |
| Q2 2023 | $45,625 | +119965.8% | 62,500 | 0.0% | 0.00% | – |
| Q1 2023 | $38 | +52.0% | 62,500 | 0.0% | 0.00% | – |
| Q4 2022 | $25 | -100.0% | 62,500 | 0.0% | 0.00% | – |
| Q3 2022 | $69,000 | +25.5% | 62,500 | 0.0% | 0.00% | – |
| Q2 2022 | $55,000 | -54.9% | 62,500 | 0.0% | 0.00% | – |
| Q1 2022 | $122,000 | -14.7% | 62,500 | 0.0% | 0.00% | – |
| Q4 2021 | $143,000 | -21.0% | 62,500 | 0.0% | 0.00% | – |
| Q3 2021 | $181,000 | – | 62,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RPO LLC | 83,705 | $98,000 | 0.02% |
| CVI Holdings, LLC | 233,930 | $257,000 | 0.02% |
| Sio Capital Management, LLC | 49,998 | $58,000 | 0.02% |
| Exos TFP Holdings LLC | 27,151 | $30,000 | 0.01% |
| TUDOR INVESTMENT CORP ET AL | 236,549 | $263,000 | 0.01% |
| LMR Partners LLP | 50,000 | $163,000 | 0.00% |
| HRT FINANCIAL LP | 42,712 | $49,000 | 0.00% |
| P SCHOENFELD ASSET MANAGEMENT LP | 19,155 | $22,000 | 0.00% |
| JANE STREET GROUP, LLC | 56,541 | $63,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |